soul trial oral semaglutide cardiovascular outcomes 2025 results Projected reduction in major adverse events among high-risk U.S. adults with type 2 diabetes eligible for semaglutide: a trial–based analysis using NHANES (1988–2018) cycles SOUL trial shows oral semaglutide
Pay in 4 interest-free payments of $5.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25





























